Getting your player ready...
NEW YORK — A judge on Monday struck down a company’s patents on two genes linked to an increased risk of breast and ovarian cancer. The ruling by U.S. District Judge Robert Sweet challenging whether anyone can hold patents on human genes was expected to have broad implications for biotechnology and genetics-based medical research.
